Skip to main content
Home

Main navigation

  • Home
  • Chairman's Message
  • Historical Development
  • Meeting Calendar
  • Contact
  • About GHWP
    • Vision, Mission and Goals
    • Terms of Reference
    • House Rules
    • Organization Structure
    • Strategic Framework
    • Legal Entity (ASL)
    • Liaison Members of GHWP
    • Activities
    • GHWP Playbook
  • Members
    • Botswana
    • Brunei Darussalam
    • Cambodia
    • Chile
    • Chinese Taipei
    • Cuba
    • Egypt
    • Ghana
    • Hong Kong SAR, China
    • India
    • Indonesia
    • Japan
    • Jordan
    • Kazakhstan
    • Kingdom of Bahrain
    • Kingdom of Saudi Arabia
    • Kyrgyz Republic
    • Laos PDR
    • Macao SAR, China
    • Malaysia
    • Mongolia
    • Myanmar
    • Pakistan
    • People's Republic of China
    • Philippines
    • Republic of Kenya
    • Republic of Korea
    • Singapore
    • South Africa
    • State of Kuwait
    • Sultanate of Oman
    • Tanzania
    • Thailand
    • United Arab Emirates
    • Uzbekistan
    • Vietnam
    • Yemen
    • Zimbabwe
  • Technical committee
    • Work Group 1 (WG1) - Pre-Market Submission and CSDT
    • Work Group 2 (WG2) - Pre-market: IVDD
    • Work Group 3 (WG3) - Pre-market: Software as a Medical Device
    • Work Group 4 (WG4) - Post-Market
    • Work Group 5 (WG5) - Clinical Evidence for Performance and Safety
    • Work Group 7 (WG7) - Quality Management System
    • Work Group 8 (WG8) - Standards
    • Work Group 9 (WG9) - UDI & Nomenclature
    • Special Task Group-Common Evaluation Reliance Practice (CERP)
    • Terms of Reference
    • Work Plan and Target
  • GHWP Academy
    • GHWP (Guangzhou) Academy
  • News
  • Events Announcements
    • Event Sponsors
  • Events
    • Photo & Video Gallery
    • Presentations
  • Country/Region Updates
  • Documents
    • Minutes
    • Reports
    • Final Documents
    • Guidance Documents
    • Reference Document
    • Forms
    • Others
  • SADS Online
  • Trade Related Issue
  • Web Resources
  • Secretariat
  • Archive
    • Background & Objectives
    • GHWP Minutes
    • TC Minutes
  • About GHWP
    • Vision, Mission and Goals
    • Terms of Reference
    • House Rules
    • Organization Structure
    • Strategic Framework
    • Legal Entity (ASL)
    • Liaison Members of GHWP
    • Activities
    • GHWP Playbook
  • Members
    • Botswana
    • Brunei Darussalam
    • Cambodia
    • Chile
    • Chinese Taipei
    • Cuba
    • Egypt
    • Ghana
    • Hong Kong SAR, China
    • India
    • Indonesia
    • Japan
    • Jordan
    • Kazakhstan
    • Kingdom of Bahrain
    • Kingdom of Saudi Arabia
    • Kyrgyz Republic
    • Laos PDR
    • Macao SAR, China
    • Malaysia
    • Mongolia
    • Myanmar
    • Pakistan
    • People's Republic of China
    • Philippines
    • Republic of Kenya
    • Republic of Korea
    • Singapore
    • South Africa
    • State of Kuwait
    • Sultanate of Oman
    • Tanzania
    • Thailand
    • United Arab Emirates
    • Uzbekistan
    • Vietnam
    • Yemen
    • Zimbabwe
  • Technical committee
    • Work Group 1 (WG1) - Pre-Market Submission and CSDT
    • Work Group 2 (WG2) - Pre-market: IVDD
    • Work Group 3 (WG3) - Pre-market: Software as a Medical Device
    • Work Group 4 (WG4) - Post-Market
    • Work Group 5 (WG5) - Clinical Evidence for Performance and Safety
    • Work Group 7 (WG7) - Quality Management System
    • Work Group 8 (WG8) - Standards
    • Work Group 9 (WG9) - UDI & Nomenclature
    • Special Task Group-Common Evaluation Reliance Practice (CERP)
    • Terms of Reference
    • Work Plan and Target
  • GHWP Academy
    • GHWP (Guangzhou) Academy
  • News
  • Events Announcements
    • Event Sponsors
  • Events
    • Photo & Video Gallery
    • Presentations
  • Country/Region Updates
  • Documents
    • Minutes
    • Reports
    • Final Documents
    • Guidance Documents
    • Reference Document
    • Forms
    • Others
  • SADS Online
  • Trade Related Issue
  • Web Resources
  • Secretariat
  • Archive
    • Background & Objectives
    • GHWP Minutes
    • TC Minutes

Log on Here

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.
Get new captcha!
  • Reset your password
Submitted by nguyen on Thu, 06/29/2017 - 22:56

After consolidating the comments received from GHWP members by 18 Nov 2016, the PROPOSED document on "Definition of the Terms “Medical Device” and “In Vitro Diagnostic (IVD) Medical Device”" developed by GHWP WG2 has become the captured PROPOSED FINAL document, for the endorsement at the 21st GHWP Meeting in Cebu.
 

Download file: Definition of the Terms “Medical Device” and “In Vitro Diagnostic (IVD) Medical Device”.pdf

Powered by Drupal. Designed by Access-2-Healthcare.

2022 All rights reserved

Footer

  • Home
  • About us
  • Contact
  • Disclaimer
  • Terms of Use
  • Home
  • Chairman's Message
  • Historical Development
  • Meeting Calendar
  • Contact